Skip to main content
. 2022 Jan 20;14(2):233. doi: 10.3390/pharmaceutics14020233

Figure 6.

Figure 6

Cancer chemoradiation. (A) Addition of radiosensitizers to tumor allows shifting the tumor controllability curve to the left. This would enable lowering of RT dose while minimizing normal tissue toxicity. (B) Progression in cell growth in MIA PaCa-2 (B-1) and PC-3 (B-2) after a 2 Gy RT dose from a clinically used linear accelerator (inset of A). * indicates p < 0.05. (C) Mapping the DNA DSBs after 24 h of the RT treatment for MIA PaCa-2. The scale bars are 20 µm.